The Republic of Mali, more commonly referred to as simply Mali, is the eighth-largest country in Africa. Mali is located in the Western part of the continent and boasts a population of approximately 25 million as of 2025. Furthermore, Mali has one of the hottest, driest climates in the world.

The Malaria Vaccine in Mali

Mali has joined the growing list of African countries that have introduced the malaria vaccine to their people. Before joining, it accounted for approximately 3.1% of global malaria cases, highlighting the country’s urgent need for innovative health interventions and stronger immunization programs.

The new initiatives on supporting the hybrid approach to the malaria vaccine in Mali began on April 25, coinciding with World Malaria Day. The Ministry of Health is leading the initiative with support from UNICEF, the World Health Organization (WHO) and Gavi, the Vaccine Alliance.

Malaria has been a massive issue for sub-Saharan African countries for years. However, recent Gavi studies have shown that a hybrid vaccination approach is practical. Mali is now applying this strategy to protect its population.

What is the New Approach?

Instead of administering the malaria vaccine two doses over a few months, the new approach in Mali provides children ages 3 to 5 with three doses spread across the year, followed by a fourth and fifth dose administered in May or June.

Children are among the most at-risk groups for contracting malaria, which is why they are the primary focus of the new vaccine initiative. Lacking years of exposure, children have not developed natural immunity as many adults have, leaving them dangerously vulnerable.

As a result, malaria remains one of the leading causes of child mortality in sub-Saharan Africa, making widespread vaccination efforts essential to saving lives and reducing future transmission.

The seasonal doses will help ensure children are as protected as possible from malaria. May and June mark the beginning of the highest transmissions of malaria in the year. Indeed, having additional vaccine doses around these times every year can help ensure that the spread doesn’t begin at all.

Has the New Approach Been Successful?

The new approach to administering the malaria vaccine in Mali has been successful, showing strong potential for long-term impact. According to the WHO, “both [doses] of vaccine reduce malaria cases by about 75% when given seasonally in areas of highly seasonal transmission where seasonal malaria chemoprevention is provided.”

With the number of childhood deaths caused by malaria trending downward, the people of Mali are becoming more optimistic about improving their children’s lives. The new vaccine initiative, coupled with more traditional methods of malaria protection, mosquito nets and repellent, ensures that the number of malaria cases continues to drop.

– Zoe Felder

Zoe is based in Charlotte, NC, USA and focuses on Good News and Global Health for The Borgen Project.

Photo: Flickr